Biotech Updates

Yield10 Bioscience Files Request for Regulatory Status Review of Omega-3 Camelina

August 2, 2023

Camelina containing the omega-3 EPA trait growing in the U.S. in spring 2023. Photo Source: Yield10 Bioscience

Yield10 Bioscience, Inc. has announced that they have filed a request for a Regulatory Status Review (RSR) with the U.S. Department of Agriculture Animal and Plant Health Inspection Service (USDA-APHIS) Biotechnology Regulatory Services (BRS) under the SECURE Rule for proprietary elite Camelina varieties containing genes that allow the plant to produce the eicosapentaenoic acid (EPA) component of omega-3 oil.

EPA is a polyunsaturated fat supplied in the human diet by consuming oily fish such as salmon, anchovies, and mackerel. Using Camelina to produce EPA may reduce the reliance on the harvest of ocean fish. Yield10 planted omega-3 (EPA) Camelina in an acre of land in the U.S. in the spring of 2023 to ramp up the seed inventory for future planting and also produce oil for their business development activities. Yield10 Bioscience signed a collaboration agreement with Rothamsted Research in the United Kingdom in late 2020 for the development of omega-3 oils in Camelina. Yield10 also signed an exclusive option for a global, exclusive, or non-exclusive license agreement to the Rothamsted omega-3 technology.

Kristi Snell, Ph.D., Chief Science Officer of Yield10 Bioscience said, “This RSR filing is a key milestone for our team as we execute our strategy to develop Camelina for large-scale production of omega-3 oils. As we await the response to our RSR filing, we remain focused on conducting seed scale-up activities to generate seed inventory for regulatory activities and future grower contracts.”

For more details, read the press release on the Yield10 Bioscience website.

You might also like: